Showing results (131-140 of 332) with videos related to

Sort By:
Pageof 34
Journal of Lipid Research|January 1, 1993
Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particlesE D Bekaert, P Alaupovic, C S Knight-Gibson, et al.
Pharmacological Research|January 1, 1996
Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytesA Corsini, L Arnaboldi, M Raiteri, et al.
Prostaglandins|February 1, 1984
The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranesM Lombroso, S Nicosia, R Paoletti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophagesS Bellosta, D Via, M Canavesi, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1997
[Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells]A Corsini, L Arnaboldi, P Quarato, et al.
Thrombosis and Haemostasis|April 26, 2000
Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination TreatmentM Cortellaro, E Cofrancesco, C Boschetti, et al.
Cytotechnology|February 24, 2012
Effect of trapidil derivative AR 12456 on intracellular cholesterol homeostasis in human hepatoma cell line Hep G2A Corsini, P Grignaffini, J Beitz, et al.
Vascular Health and Risk Management|January 19, 2008
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-dateAntonio Gaddi, A F G Cicero, F O Odoo, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1989
Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transferG Franceschini, M Sirtori, V Vaccarino, et al.
Clinical Pharmacology and Therapeutics|April 1, 1995
Microsomal enzyme inducers raise plasma high-density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemiaG Franceschini, J P Werba, A L D'Acquarica, et al.
Pageof 34